Hikal Ltd.
| BSE: 524735 | Sector: Health care |
| NSE: HIKAL | ISIN Code: INE475B01022 |
| BSE 00:00 | 24 Mar | 281.55 |
-25.15 (-8.20%) |
OPEN
305.15 |
HIGH
305.40 |
LOW
279.05 |
| NSE 00:00 | 24 Mar | 281.55 |
-25.70 (-8.36%) |
OPEN
305.90 |
HIGH
305.90 |
LOW
278.15 |
| OPEN | 305.15 |
| PREVIOUS CLOSE | 306.70 |
| VOLUME | 38104 |
| 52-Week high | 456.20 |
| 52-Week low | 215.65 |
| P/E | 54.99 |
| Mkt Cap.(Rs cr) | 3,472 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hikal Ltd. (HIKAL) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 877.00 | 7.50 | 0.86 | 2957.93 |
| Divi's Lab. | 2806.25 | 5.20 | 0.19 | 2948.54 |
| Glenmark Pharma. | 425.65 | -11.05 | -2.53 | 1997.79 |
| Glaxosmi. Pharma | 1290.15 | -4.00 | -0.31 | 1690.53 |
| Dr Reddy's Labs | 4462.30 | 14.35 | 0.32 | 1623.20 |
| Alkem Lab | 3151.40 | 2.50 | 0.08 | 1541.25 |
| Aurobindo Pharma | 500.20 | 14.05 | 2.89 | 1454.71 |
| Gland Pharma | 1283.25 | -11.40 | -0.88 | 1212.16 |
| Torrent Pharma. | 1518.10 | -13.10 | -0.86 | 991.45 |
| Sanofi India | 5668.35 | -12.35 | -0.22 | 944.40 |
| Ipca Labs. | 780.85 | -4.00 | -0.51 | 870.94 |
| Zydus Lifesci. | 480.50 | -1.85 | -0.38 | 857.90 |
| Abbott India | 21139.45 | -410.70 | -1.91 | 798.70 |
| Laurus Labs | 299.15 | -3.90 | -1.29 | 750.09 |
| Ajanta Pharma | 1182.05 | -48.75 | -3.96 | 719.86 |
| Apollo Hospitals | 4281.20 | 10.10 | 0.24 | 665.20 |
| Pfizer | 3521.35 | 5.60 | 0.16 | 612.56 |
| Suven Pharma | 472.00 | 0.60 | 0.13 | 558.10 |
| Alembic Pharma | 484.45 | -4.50 | -0.92 | 543.55 |
| Glenmark Life | 391.95 | -21.35 | -5.17 | 418.72 |
Quick Links for Hikal:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
